文献速递甲状腺疾病

儿童及年轻成人格雷夫斯病合并分化型甲状腺癌的疾病负担与结局

Disease Burden and Outcome in Children and Young Adults With Concurrent Graves Disease and Differentiated Thyroid Carcinoma.
PubMed 文献 · J Clin Endocrinol Metab · 2018-01-01

单中心回顾性纵向队列研究(1997-2016)比较12例格雷夫斯病合并分化型甲状腺癌(GD-DTC)与139例单纯DTC儿童及年轻成人,GD-DTC组诊断时年龄更大(P<0.01)、微癌更常见(P<0.01)、高细胞变异型PTC比例更高(17% vs 2%,P=0.03),但淋巴血管侵犯较少(25% vs 60%,P=0.03),2年结局无组间差异。

要点

  • GD-DTC患儿诊断时年龄更大、微癌更常见、高细胞变异型PTC比例更高。
  • GD-DTC组淋巴血管侵犯比例低于单纯DTC组(25% vs 60%)。
  • 两组2年缓解、持续疾病或复发结局无显著差异。

核心结论

  • 儿童GD合并DTC在初诊时疾病负担并不高于单纯DTC,2年结局也无显著差异。
  • 与成人相似,儿童GD-DTC中微癌和高细胞变异型PTC较为常见。
  • 对于GD-DTC患者,若在确定性治疗前超声发现结节,推荐行FNA活检以指导确定性治疗。

研究设计与样本

  • 单中心、回顾性纵向队列研究,1997年至2016年。
  • 纳入139例儿童及年轻成人DTC患者(诊断中位年龄15岁,范围5-23岁)和12例GD-DTC患者(中位年龄18岁,范围12-20岁)。

主要发现

  • GD-DTC组诊断DTC时年龄显著大于单纯DTC组(P<0.01)。
  • GD-DTC组微癌更常见(P<0.01)。
  • GD-DTC组高细胞变异型PTC为2/12(17%),单纯DTC组为2/139(2%)(P=0.03)。
  • 单纯DTC组淋巴血管侵犯更常见(60% vs 25%,P=0.03)。
  • 两组在甲状腺外侵犯、区域淋巴结转移、远处或肺转移方面无组间差异。

关键数值与推荐

  • GD-DTC患者中高细胞变异型PTC占17%(2/12),单纯DTC患者中占2%(2/139)(P=0.03)。
  • 单纯DTC组淋巴血管侵犯60%,GD-DTC组25%(P=0.03)。
  • 对于GD-DTC患者,若确定性治疗前超声发现结节,推荐行FNA活检以指导确定性治疗。

临床怎么用

  • 儿童GD患者若超声发现甲状腺结节,应行FNA活检以指导确定性治疗。
  • GD-DTC患儿的初诊疾病负担和2年结局与单纯DTC患儿无显著差异。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Adults with differentiated thyroid cancer (DTC) and Graves disease (GD) demonstrate a greater reported disease burden and aggressive DTC behavior. To date, no studies have examined the impact and long-term outcome of concurrent GD and DTC (GD-DTC) in children and young adults. DESIGN: Single institution, retrospective longitudinal cohort study between 1997 and 2016. PARTICIPANTS: One hundred thirty-nine children and young adults with DTC, diagnosed at median age 15 (range, 5 to 23) years, compared with 12 patients with GD-DTC, median age 18 (range, 12 to 20) years. MAJOR OUTCOME MEASURES: Patient demographics, preoperative imaging, fine needle aspiration (FNA) cytology, operative and pathological reports, laboratory studies, treatment, and subsequent 2-year outcomes. RESULTS: Compared with DTC, patients with GD-DTC were significantly older at the time of DTC diagnosis (P < 0.01). Patients with GD-DTC were more likely to exhibit microcarcinoma (P < 0.01), and 2 of 12 (17%) demonstrated tall cell variant papillary thyroid cancer (PTC) vs 2 of 139 (2%) in patients who had DTC alone (P = 0.03). Although patients with DTC showed greater lymphovascular invasion (60% vs 25%; P = 0.03), no group differences were noted in extrathyroidal extension, regional lymph node, and distant or lung metastasis. There were no group differences in the 2-year outcome for remission, persistent disease, or recurrence. CONCLUSIONS: Concurrent DTC in pediatric patients with GD is not associated with a greater disease burden at presentation and shows no significant difference in 2-year outcomes compared with DTC alone. Similar to adults, microcarcinoma and tall cell variant PTC is prevalent in pediatric patients with GD-DTC. For patients who have GD-DTC with an identified nodule on ultrasound imaging prior to definitive therapy, FNA biopsy is recommended to guide definitive treatment.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. MacFarland SP, Bauer AJ, Adzick NS, et al. Disease Burden and Outcome in Children and Young Adults With Concurrent Graves Disease and Differentiated Thyroid Carcinoma. J Clin Endocrinol Metab. 2018. PMID: 29788090. doi:10.1210/jc.2018-00026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。